Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Robert Findlater"'
Autor:
Apaar Sadhwani, Huang-Wei Chang, Ali Behrooz, Trissia Brown, Isabelle Auvigne-Flament, Hardik Patel, Robert Findlater, Vanessa Velez, Fraser Tan, Kamilla Tekiela, Ellery Wulczyn, Eunhee S. Yi, Craig H. Mermel, Debra Hanks, Po-Hsuan Cameron Chen, Kimary Kulig, Cory Batenchuk, David F. Steiner, Peter Cimermancic
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-11 (2021)
Abstract Both histologic subtypes and tumor mutation burden (TMB) represent important biomarkers in lung cancer, with implications for patient prognosis and treatment decisions. Typically, TMB is evaluated by comprehensive genomic profiling but this
Externí odkaz:
https://doaj.org/article/bb85166704e240079299ad3d736a4fbb
Autor:
Isabelle Auvigne-Flament, Craig H. Mermel, Peter Cimermancic, David F. Steiner, Ellery Wulczyn, Trissia Brown, Cory Batenchuk, Vanessa Velez, Apaar Sadhwani, Kamilla Tekiela, Kimary Kulig, Chang Huang-Wei, Ali Behrooz, Eunhee S. Yi, Robert Findlater, Debra Hanks, Hardik Patel, Po-Hsuan Cameron Chen, Fraser Tan
Publikováno v:
Scientific Reports
Scientific Reports, Vol 11, Iss 1, Pp 1-11 (2021)
Scientific Reports, Vol 11, Iss 1, Pp 1-11 (2021)
Both histologic subtypes and tumor mutation burden (TMB) represent important biomarkers in lung cancer, with implications for patient prognosis and treatment decisions. Typically, TMB is evaluated by comprehensive genomic profiling but this requires
Autor:
Debra Hanks, Hardik Patel, Ali Behrooz, Eunhee S. Yi, Peter Cimermancic, Huan-Wei Chang, Kimary Kulig, Robert Findlater, Kamilla Tekiela, Vanessa Velez, Apaar Sadhwani, Cory Batenchuk
Publikováno v:
Journal of Clinical Oncology. 38:3122-3122
3122 Background: The current standard work-up for both diagnosis and predictive biomarker testing in metastatic non-small cell lung cancer (NSCLC), can exhaust an entire tumor specimen. Notably, gene mutation panels or tumor mutation burden (TMB) tes